ClinicalTrials.gg
RecruitingNCT05641116LyMouv'Updated Oct 2, 2026

Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis.

An interventional study of physical activity program and Advice and recommendations of physical activity at home in Lyme Borreliosis, Physical Activity and Lyme Borreliosis, Nervous System, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Sep 2023; still recruiting 3 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 13 studies in Lyme Disease with a site in France — 5 open to participants now, 5 under way, none of them phase 3. Lyme Disease · France.

Started
2023
with 1 other
No phase
4 of 13
2 open now
Registered
6th of 13
by date
Lead sponsor
1 of 13
Centre Hospitalier Universitaire de Saint Etienne

Among the 13 studies in Lyme Disease with a site in France, this one is one of 2 that started in 2023, is one of 4 with no phase, and was the 6th registered.

Lyme Disease

98 studies on the registry are indexed under Lyme Disease; 27 are open to participants now.

Browse Lyme Disease studies →

Open to participants now

5 of the 13 studies in Lyme Disease with a site in France are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 18 Lyme Disease studies recruiting now, 11 (61%) set no upper age limit and 3 (17%) stop at 75 or younger; 7 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Lyme Disease with a site in France, or all of them as a file.
02

Study summary

Lyme borreliosis, commonly known as Lyme disease, has been clinically described for more than a century, but has been officially recognized for 40 years, with the detection of the Borrelia bacterium by W. Burgdorfer, in ticks of the Ixodes ricinus complex, identified a few years before.

Read the detailed description

Apart from the early localized presentation, with a well established treatment, Lyme borreliosis is a complex infection. Indeed, its presentation can be late and very polymorphic, which can evoke functional somatic disorders and make its management difficult. In 2016, the French Ministry of Health decided to launch a national plan to fight Lyme borreliosis. One of the objectives of this national plan was to improve management based on a specific multidisciplinary care pathway.

03

Conditions studied

  • Lyme Borreliosis
  • Physical Activity
  • Lyme Borreliosis, Nervous System

Keywords

  • sedentary time
  • therapeutic education of the patient
  • adapted physical activity
  • training program
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient referred to the reference center for tick-borne diseases by his attending physician
  • Duration of symptoms >6 months
  • At the end of the initial assessment, the diagnosis of functional somatic disorders is retained after consensus between the physicians
  • Patient practicing less than 150 minutes of regular physical activity per week (WHO recommendations)

Exclusion criteria

Exclusion Criteria:

  • Patients with cardiac or respiratory pathologies that contraindicate the practice of physical activity physical activity
  • Important comorbidities contraindicating the practice of physical activity: associated cardiac pathologies associated cardiac pathologies (severe rhythm disorders such as rapid atrial fibrillation), respiratory pathologies respiratory pathologies (obstructive or severe restrictive respiratory insufficiency), disabling joint pathologies joint pathologies (gonarthrosis or coxarthrosis limiting training on a treadmill or on a high-intensity bicycle). intensity cycling).
  • Patients under guardianship or curatorship
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
62 participants (estimated)

Study arms

  • Experimental
    Lyme Borreliosis with physical activity program

    Referral of the patient to the sport-health center of his department by the investigating physician (in connection with the attending physician for the prescription of Adaptive Physical Activity): for 24 sessions of APA for 3 months at a rate of 2 sessions/week at the sport and health center + 9 sessions of Therapeutic Patient Education in telecare

    Other: physical activity program

  • Other
    Lyme Borreliosis patients with physical activity at home

    routine clinical practice : encouragement by the attending physician to modify lifestyle habits with advice on resuming regular physical activity independently and combating sedentariness. At home, in autonomy for 3 months.

    Other: Advice and recommendations of physical activity at home

Interventions

  • Otherphysical activity program

    24 face-to-face APA sessions at the sport and health center for 3 months at a rate of 2 sessions per week near his home and 9 therapeutic patient education workshops for 3 months at a rate of 3 workshops per month (telecare).

  • OtherAdvice and recommendations of physical activity at home

    Advice and recommendations of physical activity at home (= current clinical practice in autonomy for 3 months).

06

What researchers measure

Primary outcomes

  1. Average level of moderate to vigorous physical activity (PA) - MET-h/week

    MET = metabolic equivalent This is measured with actimetry (Actigraph GT3x, Pensacola, Florida, USA).

    Time frame: 1 year after implementation of the PA program

Secondary outcomes

  1. average level of sedentary lifestyle (h/day)

    This is measured with actimetry (Actigraph GT3x, Pensacola, Florida, USA). The average sedentary time measured in industrialized countries is about 4 hours per day (excluding time spent sitting at work and in transport)

    Time frame: at Month 3, Month 6 and Month 12 after implementation of the PA program

  2. Average level of moderate to vigorous physical activity (PA) - MET-h/week

    This measured with Adult Physical Activity Questionnaire (APAQ) Score from 0 to 21 points, 0 = no difficulty, and 21= major difficulties.

    Time frame: at Month 3, Month 6 and Month 12 after implementation of the PA program

  3. Average level of sedentary lifestyle (h/day)

    This measured with Adult Physical Activity Questionnaire (APAQ) Score from 0 to 21 points, 0 = no difficulty, and 21= major difficulties.

    Time frame: at Month 3, Month 6 and Month 12 after implementation of the PA program

  4. VO2max (in ml/min/kg)

    This physical ability is measured with a cardiorespiratory test on a cycloergometer

    Time frame: at Month 3, Month 6 and Month 12 after implementation of the PA program

  5. Biceps muscular strength (kg)

    Muscular strength will be assessed by biceps muscle strength (in kilograms) on the Handgrip (JAMAR Hand Dynamometer, UK)

    Time frame: at Month 3, Month 6 and Month 12 after implementation of the PA program

  6. Patient Global Impression of Change (PGIC)

    Health status will be assessed by the Patient Global Impression of Change (PGIC) and measured on a 7-point Likert scale, rated from 1 for "much worse" to 7 for "much better".

    Time frame: at Month 3, Month 6 and Month 12 after implementation of the PA program

  7. Hospital Anxiety and Depression Scale (HADS)

    Psychological distress will be assessed using the Hospital Anxiety and Depression Scale (HADS) The HADS scale has 14 items scored from 0 to 3. 7 questions concern anxiety and 7 others the depressive dimension, which makes it possible to obtain two scores (maximum score for each score = 21). A score greater than or equal to 11 means that the anxiety or depression is anxiety or depression is certain.

    Time frame: at Month 3, Month 6 and Month 12 after implementation of the PA program

  8. Number of patients involved in the intervention

    Assessment of adherence as measured by the number of patients involved in the intervention

    Time frame: at Month 6 after implementation of the PA program

  9. medico-economic impact of the care organization

    Average cost saved per 100 patients treated in the "physical activity program group" compared to the "control group"

    Time frame: at Month 12 after implementation of the PA program

07

Study locations

1 of 2 sites recruiting
  • CHU Clermont-Ferrand
    Clermont-Ferrand, 63000, France
    Not yet recruiting
    • Clémence RICHAUD, MD · Principal investigator
    • Clément THEIS, MD · Sub investigator
  • Chu Saint Etienne
    Saint-Etienne, 42055, France
    Recruiting
    • BOTELHO-NEVERS Élisabeth, PhD · Sub investigator
    • CAZORLA Céline, MD · Sub investigator
    • David HUPIN, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2023 (actual). Primary completion is estimated for Dec 2026, 39 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2022
First posted
Dec 7, 2022
StartActual
Sep 14, 2023
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2027
Last update
Oct 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05641116
Responsible party
Sponsor
First posted
Dec 7, 2022
Start date
Sep 14, 2023
Primary completion
Dec 2026 (estimated)
Completion
Dec 2027 (estimated)
Last update
Oct 2, 2026

Study contacts

David HUPIN, MD
Contact
David.Hupin@chu-st-etienne.fr
0477828413 ext. +33
Elisabeth BOTELHO-NEVERS, MD-PhD
Contact
elisabeth.botelho-nevers@chu-st-etienne.fr
0477120762 ext. +33
David HUPIN, MD
principal investigator · CHU de Saint Etienne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion